| 000 | 01760 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515032452.0 | ||
| 264 | 0 | _c20070727 | |
| 008 | 200707s 0 0 eng d | ||
| 022 | _a0167-6806 | ||
| 024 | 7 |
_a10.1007/s10549-006-9232-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShi, Yue Y | |
| 245 | 0 | 0 |
_aProteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cNov 2006 |
||
| 300 |
_a33-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 |
_aBreast Neoplasms _xenzymology |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDual Specificity Phosphatase 1 |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmediate-Early Proteins _xmetabolism |
| 650 | 0 | 4 |
_aPhosphoprotein Phosphatases _xmetabolism |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aProtein Phosphatase 1 |
| 650 | 0 | 4 |
_aProtein Tyrosine Phosphatases _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xdrug effects |
| 700 | 1 | _aSmall, George W | |
| 700 | 1 | _aOrlowski, Robert Z | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 100 _gno. 1 _gp. 33-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-006-9232-x _zAvailable from publisher's website |
| 999 |
_c16400543 _d16400543 |
||